Challenge
In a crowded Myasthenia Gravis (MG) development landscape, a pharmaceutical sponsor needed to rapidly identify and activate PIs with proven patient access and efficient enrollment histories.
Solution
Leveraging the multi-dimensional investigator profiling capabilities of Pharma Acuity’s platform, we analyzed a high-quality dataset and segmented investigators based on enrollment performance, current commitments, trial completion, study group involvement, and network strength.
Impact
- High-performing enrollers identified in days, not weeks
- Independent validation of site readiness beyond past sponsor/CRO relationships
- Accelerated study activation with de-risked PI selection
Challenge
In an overcrowded RCC trial space, the sponsor needed to boost awareness and referrals for their immunotherapy/chemotherapy combination.
Solution
Using our LEIA platform, we built a connectivity map of diagnostic and referral influencers—integrating prescribing habits, trial participation, publications, and congress activity to reveal peer influence networks.
Impact
- Multidisciplinary physicians influencing RCC care identified
- Active HCPs in multiple networks uncovered as early trial advocates
- Accelerated awareness and referral funnel growth
Challenge
With a new ALK inhibitor entering a crowded NSCLC market, the sponsor needed to find more patients—including those being misdiagnosed or overlooked.
Solution
Our data identified community and institutional physicians diagnosing ALK and ROS mutations and flagged those underdiagnosing, plus uncovered overlooked referral networks.
Impact
- Rare lung cancer diagnoses by community physicians pinpointed
- Misdiagnosing HCPs targeted to broaden recruitment funnel